Twist Bioscience Stock Hits 80-Plus Relative Strength Rating Benchmark

Twist Bioscience Stock Hits 80-Plus Relative Strength Rating Benchmark

TwistBioscienceCorp shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.